IP Library Granted Patent US 9,028,890
Granted Patent B2
US 9,028,890 · App. 13/806,876 · Granted May 12, 2015

Composition for improving sexual wellness

Inventors: Victor Ferrari (Cointrin, CH); Frank Schönlau (Münster, DE); Carolina Burki (Cointrin, CH)
Assignee: Horphag Research (IP) Pre Ltd.
A61K36/738A61K31/352A61K31/198A61K31/353A61K36/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,028,890
App. No.
13/806,876
Granted
May 12, 2015
Kind
B2
Abstract

The invention relates to improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes with ingredients that consist in a source of proanthocyanidins, a source of arginine, rose hip extracts and/or Quercus robur extracts. The source of proanthocyanidins may be a botanical extract and the source of arginine may be from arginine aspartate.

Claims (31)

1. A method of treatment for improving sexual fitness or wellness or sexual enhancement of both sexes comprising:

administering, to a subject in need of improved sexual fitness or wellness or sexual enhancement, an effective amount of a preparation including a combination of

a first component, the first component being a source of proanthocyanidins containing rich extracts,

a second component, the second component being a source of arginine,

a third component, the third component being Rose hip and/or extracts thereof or Quercus robur and/or extracts thereof or a mixture thereof, and a suitable excipient,

wherein said first, second and third components are present in the preparation, respectively, in a weight ratio of,

20-80:400-2800:50-150, and

wherein said preparation is administered at a dosage of between 5 mg per day to 2000 mg per day.

2. The method of treatment according to claim 1 , wherein the preparation consists in a combination of:

a source of proanthocyanidins containing rich extracts,

a source of arginine,

Rose hip and/or extracts thereof and Quercus robur and/or extracts thereof, and a suitable excipient.

3. The method of treatment according to claim 1 , wherein said source of arginine is arginine or citrulline or ornithine or any arginine precursors or derivatives thereof.

4. The method of treatment of claim 3 , wherein said source of arginine is a salt or dipeptide of L-arginine and aspartic acid.

5. The method of treatment according to claim 1 , wherein said source of proanthocyanidins containing rich extracts is originated from a plant extract or from a synthesized material.

6. The method of treatment of claim 5 , wherein the plant extract is selected from the group consisting of proanthocyanidins containing extracts selected among extracts of pine bark, grape seed, apples, peanut skin, walnuts, pomegranates, raspberry, black currants, blueberry, almonds, tea, hawthorn, cocoa and combination thereof.

7. The method of treatment of claim 6 , wherein the plant extract is originated from pine bark.

8. The method of treatment according to claim 1 , wherein Rose hip and/or extracts thereof comprise carotenoids, tocopherols, tocotrienols, vitamin C, polyphenols and glycosides of mono- or di- or triacylglycerol compounds.

9. The method of treatment of claim 7 , wherein the plant extract is originated from French maritime pine bark.

10. The method of treatment according to claim 1 , wherein Rose hip and/or extracts thereof consist of Rosa canina.

11. The method of treatment according to claim 1 , wherein the suitable excipient is a pharmaceutically acceptable excipient.

12. The method of treatment according to claim 1 , wherein the preparation is in the form of a food preparation, a dietary supplement, a nutraceutical, or a beverage.

13. The method of treatment according to claim 1 , wherein the preparation is a medicament.

14. A method of treatment for treating sexual dysfunction in both sexes comprising:

administering, to a patient suffering from sexual dysfunction, an effective amount of a preparation including a combination of

a first component, the first component being a source of proanthocyanidins containing rich extracts,

a second component, the second component being a source of arginine,

a third component, the third component being Rose hip and/or extracts thereof or Quercus robur and/or extracts thereof or a mixture thereof, and a suitable excipient,

wherein said first, second and third components are present in the preparation, respectively, in a weight ratio of,

20-80:400-2800:50-150, and

wherein said preparation is administered at a dosage of between 5 mg per day to 2000 mg per day.

Assignments (2)
MERGER Recorded Jun 24, 2024
From: HORPHAG RESEARCH IP (PRE) LTD
To: HORPHAG RESEARCH IP LTD
Reel/Frame 067812/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2013
From: FERRARI, VICTOR; SCHONLAU, FRANK; BURKI, CAROLINA
To: HORPHAG RESEARCH (IP) PRE LTD.
Reel/Frame 029969/0318 →
Priority Claims (1)
CH 00470/11 · Mar 21, 2011 · national
Continuity (2)
Provisional Application 61344301 · Jun 25, 2010
Related Publication 20130164394A1 · Jun 27, 2013